SYMIC BIOMEDICAL INC has a total of 14 patent applications. Its first patent ever was published in 2014. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Brazil. Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are ALLEGRO PHARMACEUTICALS LLC, HENOGEN S A and LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES SA.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 2 | |
#3 | Brazil | 1 | |
#4 | Canada | 1 | |
#5 | Israel | 1 | |
#6 | Republic of Korea | 1 | |
#7 | Mexico | 1 | |
#8 | Singapore | 1 | |
#9 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Object sterilising |
# | Name | Total Patents |
---|---|---|
#1 | Panitch Alyssa | 10 |
#2 | Paderi John Eric | 8 |
#3 | Sharma Shaili | 6 |
#4 | Stuart Katherine Allison | 6 |
#5 | Vazquez-Portalatin Nelda Marie | 5 |
#6 | Paderi John E | 3 |
#7 | Stuart Katherine | 2 |
#8 | Park Kinam | 2 |
#9 | Freeman Lynetta Jean | 2 |
#10 | Katherine Allison Stuart | 1 |
Publication | Filing date | Title |
---|---|---|
WO2016065083A1 | Peptidoglycans comprising collagen-binding peptides for treating gastroesophageal injury | |
WO2016061145A1 | Synthetic proteoglycans for preventing tissue adhesion | |
CA2903450A1 | Extracellular matrix-binding synthetic peptidoglycans |